Cargando…
Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users
BACKGROUND: Exertional dyspnea is a hallmark symptom of fibrosing interstitial lung disease (fILD), and oxygen (O(2)) desaturation is common among patients with fILD. Supplemental O(2) is prescribed to maintain normoxia and alleviate dyspnea. We sought to better understand the associations between O...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676151/ https://www.ncbi.nlm.nih.gov/pubmed/26693009 http://dx.doi.org/10.1186/s40248-015-0035-y |